Incyte Corporation is a biopharmaceutical company that develops, discovers, and commercializes proprietary therapeutics worldwide, with its primary drugs such as JAKAFI, PEMAZYRE, and ICLUSIG. The company's current clinical stage products include ruxolitinib, itacitinib, pemigatinib, Parsaclisib, and Retifanlimab. Incyte Corporation also collaborates with Novartis International Pharmaceutical Ltd., Eli Lilly and Company, Agenus Inc., Calithera Biosciences, Inc., and many others to investigate drug combinations and develop new drugs.